The cost-effectiveness of apixaban in venous thromboembolism prevention in patients undergoing elective total knee or hip replacement in the colombian private sector
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1498
https://www.valueinhealthjournal.com/article/S1098-3015(13)01569-6/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
1069
First Page :
A289
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01569-6&doi=10.1016/j.jval.2013.03.1498